Search results
28 cze 2019 · Central sleep apneas (CSAs) occur when there is a transient reduction by the ponto-medullary respiratory rhythm generator. In contrast, obstructive sleep apnea (OSA) involves continuous respiratory efforts made against a closed airway. The four major types of sleep apnea are depicted in Figure 1.
11 lip 2023 · Central sleep apnea can be caused by a number of conditions that affect the ability of the brainstem to control breathing. The cause varies with the type of central sleep apnea you have. Types include: Cheyne-Stokes breathing. This type of central sleep apnea is most commonly associated with congestive heart failure or stroke.
CHF. Both OSA and CSA are common in CHF; however, generally, one ventilatory phenotype tends to predominate [].Variations in the haemodynamic profile of CHF patients predispose to day-to-day differences of the predominant ventilatory phenotype of apnoea [].The predominance of CSA may also shift throughout the night and, in patients predominantly exhibiting CSA with left ventricular dysfunction ...
11 cze 2023 · Describe the pathophysiology of central sleep apnea. Summarize the typical presentation with central sleep apnea. Identify the most common comorbidity associated with central sleep apnea and prognosis. Explain different treatment modalities available for patients with central sleep apnea.
7 sty 2020 · In some people, no specific cause of the disorder can be identified. This is known as idiopathic, or primary, central sleep apnea. If left untreated, sleep apnea can lead to serious health concerns. Persistent fatigue and daytime drowsiness that disrupt daily life often result from sleep apnea.
24 sty 2024 · Central sleep apnoea (CSA) is characterised by repetitive apnoeas or hypopnoeas with absent or diminished respiratory effort during sleep, occurring 5 or more times per hour. Important to search for underlying disorders such as congestive heart failure (CHF), renal failure, stroke, brainstem lesi...
Introduction. Sleep-related breathing disorders are highly prevalent in patients with established cardiovascular disease.
